Todor A Popov
Overview
Explore the profile of Todor A Popov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
1068
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Larenas-Linnemann D, Rhee C, Altraja A, Busby J, Tran T, Wang E, et al.
Tuberc Respir Dis (Seoul)
. 2025 Feb;
PMID: 39915034
The International Severe Asthma Registry (ISAR) was established in 2017 to advance the understanding of severe asthma and its management, thereby improving patient care worldwide. As the first global registry...
2.
Asllani A, Asllani J, Mitsias D, Konstantinou G, Qirko E, Hitaj M, et al.
Allergy
. 2024 Aug;
80(3):775-784.
PMID: 39175252
Background: Registries can yield important insights on allergen immunotherapy (AIT) outcomes in daily clinical practice. However, systematic recordings of adverse events (AE) due to AIT in real-life are lacking. Methods:...
3.
Bousquet J, Schunemann H, Sousa-Pinto B, Zuberbier T, Togias A, Samolinski B, et al.
J Allergy Clin Immunol Pract
. 2024 Jul;
12(10):2648-2668.e2.
PMID: 38971567
The traditional healthcare model is focused on diseases (medicine and natural science) and does not acknowledge patients' resources and abilities to be experts in their own lives based on their...
4.
Denton E, Hew M, Peters M, Upham J, Bulathsinhala L, Tran T, et al.
Allergy
. 2024 Jun;
79(10):2700-2716.
PMID: 38923444
Background: Biologic asthma therapies reduce exacerbations and long-term oral corticosteroids (LTOCS) use in randomized controlled trials (RCTs); however, there are limited data on outcomes among patients ineligible for RCTs. Hence,...
5.
Scelo G, Tran T, Le T, Fageras M, Dorscheid D, Busby J, et al.
J Allergy Clin Immunol Pract
. 2024 May;
12(9):2347-2361.
PMID: 38768896
Background: Biologic effectiveness is often assessed as response, a term that eludes consistent definition. Identifying those most likely to respond in real-life has proven challenging. Objective: To explore definitions of...
6.
Porsbjerg C, Townend J, Bergeron C, Christoff G, Katsoulotos G, Larenas-Linnemann D, et al.
Front Immunol
. 2024 May;
15:1361891.
PMID: 38711495
Background: To date, studies investigating the association between pre-biologic biomarker levels and post-biologic outcomes have been limited to single biomarkers and assessment of biologic efficacy from structured clinical trials. Aim:...
7.
Perez-de-Llano L, Scelo G, Tran T, Le T, Fageras M, Cosio B, et al.
Am J Respir Crit Care Med
. 2024 May;
210(7):869-880.
PMID: 38701495
There is no consensus on criteria to include in an asthma remission definition in real life. Factors associated with achieving remission after biologic initiation remain poorly understood. To quantify the...
8.
Reshef A, Buttgereit T, Betschel S, Caballero T, Farkas H, Grumach A, et al.
J Allergy Clin Immunol
. 2024 Apr;
154(2):398-411.e1.
PMID: 38670233
Background: Angioedema (AE) manifests with intermittent, localized, self-limiting swelling of the subcutaneous and/or submucosal tissue. AE is heterogeneous, can be hereditary or acquired, may occur only once or be recurrent,...
9.
Lee T, Price D, Yadav C, Roy R, Lim L, Wang E, et al.
Chest
. 2024 Feb;
166(1):28-38.
PMID: 38395297
Background: Exacerbation frequency strongly influences treatment choices in patients with severe asthma. Research Question: What is the extent of the variability of exacerbation rate across countries and its implications in...
10.
Chen W, Tran T, Sadatsafavi M, Murray R, Boon Wong N, Ali N, et al.
J Allergy Clin Immunol Pract
. 2024 Feb;
12(2):536-539.
PMID: 38336403
No abstract available.